Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/4/2022 | Hold → Speculative Buy | Mackie Research | |
| 11/17/2021 | $7.00 → $4.50 | Outperform → Market Perform | Raymond James |
| 10/14/2021 | $9.00 | Outperform | Northland Capital |
| 8/2/2021 | $8.00 | Buy | Lake Street |
TORONTO, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, today announced its financial results for the second quarter ended June 30, 2022. Doubles revenue to $16.1 million vs $7.7 million in the previous quarter and 134% Year over Year.Gross profit margin of 25%, down from the previous quarter of 44% primarily driven by the Capitated revenue from full-risk Value Based Care ("VBC") contracts with the acquisition of NeighborMD ("NMD"). Capitated revenue has lower Gross Margins but much higher dollar contribution.Adjusted EBITDA loss improved by 19% fr
TORONTO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, is pleased to announce that its financial results for the second quarter of 2022 will be released after the close of market on August 15th, 2022. The Company will host a conference call at 8:00am EDT on the morning of August 16, 2022 to discuss the financial results and outlook for the Company. If you would like to participate in the call, details can be found below. Please dial in approximately 10 minutes prior to the start of the call. Conference Call Details Date:August 16, 2022Time:8
TORONTO, July 20, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares (the "Series A Preferred Shares") for the month of August 2022. The Series A Preferred Shares trade under the "SLHGP" stock ticker symbol. In accordance with the terms of the Series A Preferred Shares, the Series A dividend will be payable in cash in the amount of $0.1927 per share on August 22, 2022 to the shareholders of record
Mackie Research upgraded Skylight Health Group from Hold to Speculative Buy
Raymond James downgraded Skylight Health Group from Outperform to Market Perform and set a new price target of $4.50 from $7.00 previously
Northland Capital initiated coverage of Skylight Health Group with a rating of Outperform and set a new price target of $9.00
15-12G/A - Skylight Health Group Inc. (0001839730) (Filer)
15-12G - Skylight Health Group Inc. (0001839730) (Filer)
6-K - Skylight Health Group Inc. (0001839730) (Filer)
TORONTO, July 14, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, today announced the re-appointment of Co-Founder and current Director and Chief Corporate Officer Kash Qureshi as President. Prad Sekar, CEO and Co-Founder of Skylight Health said, "What has made us resilient in any environment is having both co-founders working side by side for over 12 years. Kash and I will continue to execute our plan to bring Skylight into profitability in 2022. We are fortunate to have an experienced and highly capable senior management team who will continue to lead our
TORONTO, June 29, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, is pleased to announce the results of voting at its annual general meeting of the shareholders which was held today (the "Meeting"). All matters submitted to the shareholders, as set out in the Company's Notice of Meeting and Management Information Circular, were approved by the requisite majority of votes cast at the Meeting. Election of Directors Each of the nominees for election as directors listed in the management information circular of the Corporation dated May 13, 2022, was elected a
TORONTO, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, today announced the appointment of Mohammad Bataineh as the Company's new President. Brings over 25 years of experience working in primary care, healthcare M&A, integrations, legal and operations;Will be responsible for management and execution of all internal functions including coordination with clinical, financial, and technology teams;Co-Founder Kash Qureshi will shift focus to Corporate Affairs, including Corporate Development, and will retain executive leadership while overseeing the Tec
TORONTO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SLHG) ("Skylight Health" or the "Company"), a healthcare platform combining technology and analytics focused on transitioning patients into value based care to drive better health outcomes and experiences in the United States, today provides a general corporate update on the status of the Company's initiatives to drive organic growth, continue on its pathway to profitability and expansion of value based care contracts. Over 15% growth in patient visits in August 2022 vs July 2022 driven by newly implemented contact center and other marketing initiatives;Over $10 million reduction from forecasted annual costs driv
TORONTO, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, is pleased to announce that it has closed the non-brokered private placement announced on August 8, 2022 (the "Offering"), issuing 2,355 units of unsecured convertible debentures ("Debentures"). The principal sum of Debentures issued totals C$2,355,000. Prad Sekar, CEO & Co-Founder of Skylight Health said, "We have a strong history of being diligent in our capital raising to ensure minimal dilution, and this cash injection gives us a buffer to get us comfortably to cash flow positivity." The
TORONTO, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, today announced its financial results for the second quarter ended June 30, 2022. Doubles revenue to $16.1 million vs $7.7 million in the previous quarter and 134% Year over Year.Gross profit margin of 25%, down from the previous quarter of 44% primarily driven by the Capitated revenue from full-risk Value Based Care ("VBC") contracts with the acquisition of NeighborMD ("NMD"). Capitated revenue has lower Gross Margins but much higher dollar contribution.Adjusted EBITDA loss improved by 19% fr
Gainers Virax Biolabs Group Limited (NASDAQ:VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023. Addex Therapeutics Ltd (NASDAQ:ADXN) gained 110.4% to close at $1.93 after the company issued corporate update and financial guidance. The company announced the reduction of its issued, authorized and conditional share capital from CHF 1.00 to CHF 0.01 and provided corporate updates. 1Life Healthcare, Inc. (NASDAQ:ONEM) gained 69.5% to close at $17.25 after Amazon announced it will acquire the company for $18 per share in an all-cash transaction valu
Gainers Virax Biolabs Group Limited (NASDAQ:VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023. Addex Therapeutics Ltd (NASDAQ:ADXN) jumped 131.1% to $2.12 after the company issued corporate update and financial guidance. 1Life Healthcare, Inc. (NASDAQ:ONEM) gained 68% to $17.10 after Amazon announced it will acquire the company for $18 per share in an all-cash transaction valued at approximately $3.9 billion. Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) shares jumped 47.3% to $3.8299 after the company said it expects Q2 sales of $72 – $73 million, exceeding the
During Tuesday's session, 539 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the biggest company by market cap to set a new 52-week low. The smallest company on a market cap basis to set a new 52-week low was ThermoGenesis Holdings (NASDAQ:THMO). Kalera (NASDAQ:KAL)'s stock dropped the most, trading down 21.6% to reach a new 52-week low. CommScope Hldg Co (NASDAQ:COMM)'s stock made the biggest reversal, trading up 0.0% shortly after dropping to a new 52-week low. Here are all the stocks that set new 52-week lows on Tuesday: Taiwan Semiconductor (NYSE:TSM) stock broke to a new 52-week low of $73.74 on Tuesday. Sha